Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 27

1.

[Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].

Geng SX, DU X, Weng JY, Zhong LY, Guo R, Lu ZS, Chen ZH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1424-8. Chinese.

PMID:
20030919
2.

Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.

Choi J, Hwang YK, Sung KW, Kim DH, Yoo KH, Jung HL, Koo HH.

Leuk Res. 2006 Aug;30(8):1019-25. Epub 2006 Jan 18.

PMID:
16388850
3.

Akt regulation of Aven contributes to the sensitivity of cancer cells to chemotherapeutic agents.

Han KY, Hwang JW, Bae GU, Kim SN, Kim YK.

Mol Med Rep. 2015 May;11(5):3866-71. doi: 10.3892/mmr.2015.3158. Epub 2015 Jan 8.

PMID:
25573060
4.

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.

Eißmann M, Melzer IM, Fernández SB, Michel G, Hrabě de Angelis M, Hoefler G, Finkenwirth P, Jauch A, Schoell B, Grez M, Schmidt M, Bartholomae CC, Newrzela S, Haetscher N, Rieger MA, Zachskorn C, Mittelbronn M, Zörnig M.

Oncogene. 2013 May 16;32(20):2586-91. doi: 10.1038/onc.2012.263. Epub 2012 Jul 2.

PMID:
22751129
5.

The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.

Melzer IM, Fernández SB, Bösser S, Lohrig K, Lewandrowski U, Wolters D, Kehrloesser S, Brezniceanu ML, Theos AC, Irusta PM, Impens F, Gevaert K, Zörnig M.

Cell Death Differ. 2012 Sep;19(9):1435-45. doi: 10.1038/cdd.2012.17. Epub 2012 Mar 2.

6.

Apoptosis-inhibitor Aven is downregulated in defective spermatogenesis and a novel estrogen target gene in mammalian testis.

Laurentino S, Gonçalves J, Cavaco JE, Oliveira PF, Alves MG, de Sousa M, Barros A, Socorro S.

Fertil Steril. 2011 Sep;96(3):745-50. doi: 10.1016/j.fertnstert.2011.06.009. Epub 2011 Jun 30.

PMID:
21718987
7.

Regulation of the ATM-activator protein Aven by CRM1-dependent nuclear export.

Esmaili AM, Johnson EL, Thaivalappil SS, Kuhn HM, Kornbluth S, Irusta PM.

Cell Cycle. 2010 Oct 1;9(19):3913-20. Epub 2010 Oct 25.

PMID:
20935510
8.

Aven-dependent activation of ATM following DNA damage.

Guo JY, Yamada A, Kajino T, Wu JQ, Tang W, Freel CD, Feng J, Chau BN, Wang MZ, Margolis SS, Yoo HY, Wang XF, Dunphy WG, Irusta PM, Hardwick JM, Kornbluth S.

Curr Biol. 2008 Jul 8;18(13):933-42. doi: 10.1016/j.cub.2008.05.045. Epub 2008 Jun 19.

9.
10.

Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.

Baranski Z, Booij TH, Cleton-Jansen AM, Price LS, van de Water B, Bovée JV, Hogendoorn PC, Danen EH.

J Pathol. 2015 Jul;236(3):348-59. doi: 10.1002/path.4528. Epub 2015 Mar 30.

PMID:
25757065
11.

Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes.

Thandapani P, Song J, Gandin V, Cai Y, Rouleau SG, Garant JM, Boisvert FM, Yu Z, Perreault JP, Topisirovic I, Richard S.

Elife. 2015 Aug 12;4. doi: 10.7554/eLife.06234.

12.

Transcriptome sequencing of malignant pleural mesothelioma tumors.

Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3521-6. doi: 10.1073/pnas.0712399105. Epub 2008 Feb 26.

13.

Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.

Chau BN, Cheng EH, Kerr DA, Hardwick JM.

Mol Cell. 2000 Jul;6(1):31-40.

14.

Microsatellite scan identifies new candidate genes for susceptibility to alcoholic chronic pancreatitis in Japanese patients.

Kitahara K, Kawa S, Katsuyama Y, Umemura T, Ozaki Y, Takayama M, Arakura N, Ota M.

Dis Markers. 2008;25(3):175-80.

15.

Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.

Ruaño G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S.

Clin Chim Acta. 2009 Feb;400(1-2):48-55. doi: 10.1016/j.cca.2008.10.009. Epub 2008 Oct 26.

PMID:
18996102
16.

Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?

Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH.

Pharmacogenomics. 2010 Jul;11(7):959-71. doi: 10.2217/pgs.10.58.

17.

Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.

Flachsbart F, Franke A, Kleindorp R, Caliebe A, Blanché H, Schreiber S, Nebel A.

Mutat Res. 2010 Dec 10;694(1-2):13-9. doi: 10.1016/j.mrfmmm.2010.08.006. Epub 2010 Aug 26.

PMID:
20800603
18.

Phosphoproteomic analysis of the developing mouse brain.

Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP.

Mol Cell Proteomics. 2004 Nov;3(11):1093-101. Epub 2004 Sep 2.

19.

High-throughput mapping of a dynamic signaling network in mammalian cells.

Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL.

Science. 2005 Mar 11;307(5715):1621-5.

20.

Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S; DREAM investigators.

Diabetes Care. 2010 Oct;33(10):2250-3. doi: 10.2337/dc10-0452. Epub 2010 Jul 13.

Supplemental Content

Support Center